SIC
NVCR icon

Sigma Investment Counselors’s NovoCure NVCR Stock Holding History

Sigma Investment Counselors’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,121
Closed -$249K – 194
2021
Q2 		$249K Buy
+1,121
New +$218K 0.02% 170

Other funds holding NVCR

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sigma Investment Counselors's NVCR Position: Q3 2021 in Review

Sigma Investment Counselors sold out of NovoCure (NVCR) in Q3 2021, closing a stake of 1,121 shares — an estimated $249K sold.

Sigma Investment Counselors first reported a position in NVCR in Q2 2021 and held it in 1 quarter. The position peaked at $249K in Q2 2021. 318 funds tracked by Wall St. Rank hold NVCR as of Q3 2021.

  • Sigma Investment Counselors reported no remaining NovoCure position as of Q3 2021 after selling out during the quarter.
  • Sigma Investment Counselors sold 1,121 NovoCure shares in Q3 2021, an estimated $249K.
  • Sigma Investment Counselors first reported a position in NovoCure in Q2 2021 and held it in 1 quarter.
  • Sigma Investment Counselors's NovoCure position peaked at $249K in Q2 2021.
  • 318 funds tracked by Wall St. Rank held NovoCure as of Q3 2021.

Based on Sigma Investment Counselors's 13F filing for Q3 2021, filed 5 Nov 2021.